Insulin inhibits hepatocyte iNOS expression induced by cytokines by an Akt-dependent mechanism.

Hepatocyte inducible nitric oxide synthese (iNOS) expression is a tightly controlled pathway that mediates hepatic inflammation and hepatocyte injury in a variety of disease states. We have shown that cyclic adenosine monophosphate (cAMP) regulates cytokine-induced hepatocyte iNOS expression through mechanisms that involve protein kinase B/Akt. We hypothesized that insulin, which activates Akt signaling in hepatocytes, as well as signaling through p38 and MAPK p42/p44, would regulate iNOS expression during inflammation. In primary rat hepatocytes, insulin inhibited cytokine-stimulated nitrite accumulation and iNOS expression in a dose-dependent manner. Inhibition of MAPK p42/p44 with PD98059 had no effect on iNOS activation, whereas SB203580 to block p38 reversed insulin's inhibitory effect. However, insulin did not increase p38 activation and inhibition of p38 signaling with a dominant negative p38 plasmid had no effect on cytokine- or insulin-mediated effects on iNOS. We found that SB203580 blocked insulin-induced Akt activation. Inhibition of Akt signaling with LY294002 or a dominant negative Akt plasmid increased cytokine-stimulated nitrite production and iNOS protein expression and blocked the inhibitory effects of insulin. NF-κB induces iNOS expression and can be regulated by Akt, but insulin had no effect on cytokine-mediated IκBα levels or NF-κB p65 translocation. Our data demonstrate that insulin inhibits cytokine-stimulated hepatocyte iNOS expression and does so through effects on Akt-mediated signaling.

[1]  B. Harbrecht,et al.  Cyclic AMP inhibits IL-1beta plus IFNgamma-induced NF-kappaB translocation in hepatocytes by a PKA independent mechanism. , 2010, The Journal of surgical research.

[2]  M. Bauer,et al.  PROSPECTIVE ASSESSMENT OF HEPATIC FUNCTION AND MECHANISMS OF DYSFUNCTION IN THE CRITICALLY ILL , 2009, Shock.

[3]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[4]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[5]  Tian-Le Xu,et al.  Akt inhibits MLK3/JNK3 signaling by inactivating Rac1: a protective mechanism against ischemic brain injury , 2006, Journal of neurochemistry.

[6]  Mirjam Christ-Crain,et al.  Diabetes and hyperglycemia: Strict glycemic control , 2006, Critical care medicine.

[7]  N. Borradaile,et al.  Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. , 2005, Diabetes.

[8]  O. Szold,et al.  Glucose control by insulin for critically ill surgical patients. , 2004, The Journal of trauma.

[9]  H. Yoshida,et al.  Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1β at a step of NF-κB DNA binding in hepatocytes , 2004 .

[10]  K. Woodcroft,et al.  Insulin Signaling Regulates γ-Glutamylcysteine Ligase Catalytic Subunit Expression in Primary Cultured Rat Hepatocytes , 2004, Journal of Pharmacology and Experimental Therapeutics.

[11]  D. Maysinger,et al.  Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. , 2004, Endocrinology.

[12]  L. Phillips,et al.  Insulin-response Element-binding Protein 1 , 2004, Journal of Biological Chemistry.

[13]  C. Webster,et al.  Activation of cAMP-guanine exchange factor confers PKA-independent protection from hepatocyte apoptosis. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[14]  B. Harbrecht,et al.  GLUCAGON REGULATES HEPATIC INDUCIBLE NITRIC OXIDE SYNTHESIS IN VIVO , 2004, Shock.

[15]  B. Harbrecht,et al.  JNK signaling involved in the effects of cyclic AMP on IL-1β plus IFNγ-induced inducible nitric oxide synthase expression in hepatocytes , 2004 .

[16]  Wan-Wan Lin,et al.  PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. , 2004, Cellular signalling.

[17]  Sang Hyun Kim,et al.  Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. , 2004, Pharmacological research.

[18]  C. Figueroa,et al.  Akt2 Negatively Regulates Assembly of the POSH-MLK-JNK Signaling Complex* , 2003, Journal of Biological Chemistry.

[19]  A. Barthel,et al.  Novel concepts in insulin regulation of hepatic gluconeogenesis. , 2003, American journal of physiology. Endocrinology and metabolism.

[20]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[21]  Marie C. M. Lin,et al.  Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. , 2003, Diabetes.

[22]  P. Cohen,et al.  The specificities of protein kinase inhibitors: an update. , 2003, The Biochemical journal.

[23]  S. Tominaga,et al.  TRAF6 and C-SRC induce synergistic AP-1 activation via PI3-kinase-AKT-JNK pathway. , 2003, European journal of biochemistry.

[24]  A. Keeton,et al.  Insulin Signal Transduction Pathways and Insulin-induced Gene Expression* , 2002, The Journal of Biological Chemistry.

[25]  C. Webster,et al.  cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[26]  A. Peitzman,et al.  Hepatic dysfunction increases length of stay and risk of death after injury. , 2002, The Journal of trauma.

[27]  D. Brenner,et al.  Akt protects mouse hepatocytes from TNF-α- and Fas-mediated apoptosis through NK-κB activation , 2001 .

[28]  G. V. Berghe,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[29]  K. Moelling,et al.  Regulation of Raf by Akt Controls Growth and Differentiation in Vascular Smooth Muscle Cells* , 2001, The Journal of Biological Chemistry.

[30]  B. Harbrecht,et al.  cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured rat hepatocytes. , 2001, The Journal of surgical research.

[31]  Y. Vodovotz,et al.  Catecholamines decrease nitric oxide production by cytokine-stimulated hepatocytes. , 2001, Surgery.

[32]  R. Walther,et al.  REGULATION OF GLUCOSE-6-PHOSPHATASE GENE EXPRESSION BY PROTEIN KINASE B AND THE FORKHEAD TRANSCRIPTION FACTOR FKHR , 2001 .

[33]  R. Walther,et al.  Regulation of Glucose-6-phosphatase Gene Expression by Protein Kinase Bα and the Forkhead Transcription Factor FKHR , 2000, The Journal of Biological Chemistry.

[34]  C. Sutherland,et al.  NF-κB Inhibits Glucocorticoid and cAMP-mediated Expression of the Phosphoenolpyruvate Carboxykinase Gene* , 2000, The Journal of Biological Chemistry.

[35]  T. Billiar,et al.  Cyclic Nucleotides Suppress Tumor Necrosis Factor α-Mediated Apoptosis by Inhibiting Caspase Activation and Cytochrome cRelease in Primary Hepatocytes via a Mechanism Independent of Akt Activation* , 2000, The Journal of Biological Chemistry.

[36]  K. Moelling,et al.  Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.

[37]  Simon C Watkins,et al.  A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. , 1999, The American journal of physiology.

[38]  C. Glass,et al.  Nuclear Integration of Glucocorticoid Receptor and Nuclear Factor-κB Signaling by CREB-binding Protein and Steroid Receptor Coactivator-1* , 1998, The Journal of Biological Chemistry.

[39]  David A. Geller,et al.  Multiple NF-κB Enhancer Elements Regulate Cytokine Induction of the Human Inducible Nitric Oxide Synthase Gene* , 1998, The Journal of Biological Chemistry.

[40]  S. Ghosh,et al.  Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. , 1998, Molecular cell.

[41]  A. Peitzman,et al.  Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock , 1998, The Journal of experimental medicine.

[42]  T. Billiar,et al.  Glucagon inhibits hepatocyte nitric oxide synthesis. , 1996, Archives of surgery.

[43]  K. Fearon,et al.  Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. , 1995, The American journal of physiology.

[44]  J. Singer,et al.  A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. , 1993, Chest.

[45]  S. Kaye,et al.  Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. , 1989, Cancer research.

[46]  B. Harbrecht,et al.  Akt-mediated signaling is induced by cytokines and cyclic adenosine monophosphate and suppresses hepatocyte inducible nitric oxide synthase expression independent of MAPK P44/42. , 2011, Biochimica et biophysica acta.

[47]  Renda Soylemez Wiener,et al.  Ill Adults: A Meta-analysis Benefits and Risks of Tight Glucose Control in Critically , 2010 .

[48]  L. Phillips,et al.  Insulin-response Element-binding Protein 1 A NOVEL Akt SUBSTRATE INVOLVED IN TRANSCRIPTIONAL ACTION OF INSULIN* , 2004 .

[49]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[50]  A. Baue,et al.  Multiple Organ Failure , 2000, Springer New York.

[51]  E. Isenovic,et al.  Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. , 1999, Hypertension.